ABBV
AbbVie Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$292.01
+2.10%Forward multiples
Based on analyst estimates
- P/E forward
- 18.55x
- P/E 2026E
- 20.73x
- P/E 2027E
- 17.77x
- P/E 2028E
- 16.06x
- P/S forward
- 7.22x
Trailing multiples
Trailing twelve months
- P/E TTM
- 50.09x
- PEG TTM
- 0.29x
- Price / book
- —
- Price / sales
- 7.82x
- Price / cash flow
- 27.12x
Enterprise value
- Enterprise value
- —
- EV / sales
- —
- EV / EBITDA
- —
- EV / EBIT
- —
- Market cap
- $516.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026